Abstract

Recreational cocaine use in the UK is steadily rising. This review summarises some of the common clinical manifestations of cocaine use which may be encountered by acute physicians and discusses the available treatment options.
[download-attachments container="div" style="list" dipslay_icon="1" display_count="1" display__size="0"]

References

1. EMCDDA. Annual Report 2006: the state of the drug problem in Europe. Chapter 5.
2. FRANK A-Z of drugs- Cocaine. Crown Copyright 2003. [online] Available: http://www.talktofrank.com/drugs.aspx?id=106#cost (accessed July 2007).
3. Egred E & Davis GK. Cocaine and the heart. Postgrad Med J 2005; 81: 568–571.
4. Lange RA & Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med Aug 2001; 345(5): 351–359.
5. Wilbert-Lampen U, Seliger C, Zilker T, et al. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation 1998; 98: 385–90.
6. Mo W, Singh AK, Arruda JA, et al. Role of nitric oxide in cocaineinduced acute hypertension. Am J Hypertens 1998; 11: 708–14.
7. Minor RL, Jr., Scott BD, Brown DD, et al. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 1991; 115: 797–806.
8. Togna G, Tempesta E, Togna AR, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis 1985; 15: 100–7.
9. Vongpatanasin W, Mansour Y, Chavoshan B, et al. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 1999; 100: 497–502.
10. Terefe YG, Niraj A, Pradhan J, et al. Myocardial infarction with angiographically normal coronary arteries in the contemporary era. Coron Artery Dis 2007; 18(8): 621–626.
11. Dressler FA, Malekzadeh S, Roberts WC. Quantitatie analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 1990; 65: 303–308.
12. Chase M, Brown AM, Robey JL, et al. Application of the TIMI risk score in ED patients with cocaine-associated chest pain. Am J Emerg Med 2007; 25: 1015–1018.
13. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation 2007; 116: 148–304.
14. Bhangoo P, Parfitt A, Wu T. Cocaine induced myocardial ischaemia: nitrates versus benzodiazepines. EMJ 2006; 23: 568–569.F
15. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaineinduced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990 15; 112(12): 897–903.
16. Fareed FN, Chan G, Hoffman RS. Death temporally related to the use of a beta-adrenergic receptor antagonist incocaine associated myocardial infacrtion. J Med Toxicol 2007; 3(4): 169–172.
17. Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetolol on cocaineinduced coronary vasoconstriction in humans. Am J Med 1993; 94: 608–610.
18. Menon DV, Wang Z, Fadel PJ, et al. Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activstion and vasoconstriction in humans. J Am Col Cardiol 2007; 50(7): 626–633.
19. Hollander JE. The management of cocaine-associated myocardial ischaemia. N Engl J Med 1995; 333: 1267–1272.
20. Weber JE, Shofer FS, Larkin GL, et al. Validation of a brief observation period for patients with cocain-associated chest pain. N Engl J Med 2003; 348: 510–517.
21. Hollander JE, Hoffman RS, Gennis P, et al. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med 1994; 1:330– 339.
22. Afonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol 2007; 100: 1040–1043.
23. Bertolet BD, Freund G, Martin CA, et al. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol 1990; 13: 323–328.
24. Daga B, Minano A, de la Peurta I, et al. Electrocardiographic findings typical of Brugada syndrome unmasked by cocaine consumption. Rev Esp Cardiol 2005; 58: 1355–1357.
25. Daniel JC, Huynh TT, Zhou W, et al. Acute aortic dissection associated with use of cocaine. J Vasc Surg 2007; 46: 427–433.
26. Hsue PY, Salinas CL, Bolger AF, et al. Acute aortic dissection related to crack cocaine. Circulation 2002; 22 Spec No: S119–135.
27. Seaman ME. Barotrauma related to inhalational drug abuse. J Emerg Med 1990; 8: 141–149.
28. Hazouard E, Koninck JC, Attucci S, et al. Pneumorachis and pneumomediastinum caused by repeated Müller’s maneuvers: complications of marijuana smoking. Ann Emerg Med 2001 Dec; 38(6): 694–7.
29. Mutlu H, Silit E, Pekkafali Z, et al.’Ecstasy’(MDMA)-induced pneumomediastinum and epidural pneumatosis. Diagn Interv Radiol 2005 Sep; 11(3): 150–1.
30. Bernaerts A, Verniest T, Vanhoenacker F, et al. Pneumomediastinum and epidural pneumatosis after inhalation of “Ectasy”. Eur Radiol 2003 Mar; 13(3): 642–3.
31. Murray RJ, Albin RJ, Mergner W, et al. Diffuse alveolar hemorrhage temporally relted to cocaine smoking. Chest 1988; 93: 427–429.
32. Kissner DG, Lawrence WD, Selis JE, et al. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1987; 136; 5: 1250–1252.
33. Forrester JM, Steele AW, Waldron JA, et al. Crack lung: acute pulmonary syndrome with a spectrum of clinical and histopathological findings. Am Rev Respir Dis 1990; 142(2): 462–467.
34. Hirche TO, Lambrecht E, Wagner TO. Crack-syndrome: the pulmonary complications of inhaled cocaine. A review a propos a case report. Pneumonologie 2002 Nov; 56(11): 684–8.
35. Wolff AJ, O’Donnell AE. Pulmonary effects of illicit drug use. Clin Chest Med 2004; 25: 203–216.